In terms of mechanism, FKBP1A was found to bind with SLC3A2, and negatively regulated SLC3A2 expression during the processes of everolimus inducing ferroptosis of BC cells and promoting anti-proliferation of Th9 cells. This evidence concerns the gene FKBP1A and breast cancer.